Eighth patent in UC’s wide-ranging CRISPR-Cas9 portfolio involves introducing Cas9 into a cell for genome editing BERKELEY, Calif., July 16, 2019 /PRNewswire/ — The U.S. Patent and Trademark Office (USPTO)...
Emerging technologies
Casebia Highlights Novel Research in Gene Editing Therapeutics for Hemophilia A
Early-stage animal model data presented during the ISTH 2019 Congress demonstrates ability to edit hepatocytes and accurately tune production of Factor VIII CAMBRIDGE, Mass.–(BUSINESS WIRE)–Casebia...
